Showing 1 posts of 1 posts found.
GlaxoSmithKline has sold off half its stake in South Africa’s Aspen Pharmacare in a move that will net the British …
New CCO Ogburn joins Cori Clinical
Claris reports visual acuity gains with experimental LSCD treatment
Amphista doses first patient in AML trial of protein degrader
First 90 days of antipsychotic treatment linked to rapid metabolic changes
Jennings becomes President of Beckman Coulter Diagnostics